Apidra Solostar Ready Pen Sanofi
€241.00
Buying Apidra Solostar Ready Pen Sanofi is easy trusted online store in English
In today’s fast-paced world, managing diabetes effectively is crucial, especially for athletes and individuals seeking optimal performance. The Apidra Solostar Ready Pen makes it easier for users to deliver insulin conveniently and accurately. This insulin pen is widely available through trusted online stores, providing a reliable source at competitive prices. By purchasing from reputable retailers, you ensure authentic products that comply with safety regulations. It’s essential to review the store’s reputation, customer reviews, and return policies before making a purchase. This attention to detail can save time and potential health risks. Take a step toward improved diabetes management by finding the Apidra Solostar Ready Pen online today.
General information about Apidra Solostar Ready Pen Sanofi formulation and presentation
The Apidra Solostar Ready Pen from Sanofi contains insulin glulisine, a rapid-acting insulin analog designed to mimic the body’s natural insulin response to food intake. Each pen comprises 3 mL of insulin glulisine in a sterile, prefilled, disposable container. Users appreciate the user-friendly design, complete with a dose selector for precise and simple administration. The pen is ideal for individuals managing diabetes and engages in athletic activities, allowing them to maintain better control over their blood glucose levels. Its rapid onset and therapeutic flexibility make it a preferred choice for those who require fast-acting insulin.
Mechanism of action effects on metabolism
Insulin glulisine, the active ingredient in Apidra, works intricately to reduce blood glucose levels. Upon administration, the insulin binds to insulin receptors on cell membranes, facilitating glucose uptake by muscle and adipose tissues. This rapid absorption and action mean that glucose is utilized for energy rather than remaining in the bloodstream, which is critical for athletes who rely on glucose for optimal performance. By directly enhancing cellular glucose uptake, Apidra decreases blood glucose concentrations swiftly, approximately 10-15 minutes after injection, with peak effects occurring around 1 hour post-administration. Additionally, the reduced incidence of hypoglycemia is a considerable advantage, making it suitable for individuals engaged in physical activity.
Benefits faster recovery, greater potency
The Apidra Solostar Ready Pen offers significant benefits, especially for athletes aiming for enhanced performance and quicker recovery times. Some of these benefits include:
- Accelerated glucose metabolism
- Improved energy availability during workouts
- Reduced risk of hypoglycemic episodes
- Convenient and precise dosing
- Flexible administration around meal times
Athletes often struggle with maintaining optimal glucose levels, and the rapid action of Apidra serves to mitigate this challenge. Users report that improved energy levels and reduced recovery times contribute significantly to overall performance. With the ability to manage blood glucose levels more effectively, athletes can focus on their training and performance without the constant worry of glucose fluctuations. The portability and ease of use of the Apidra Solostar Ready Pen add to its appeal, making it a favored choice among health-conscious sports enthusiasts.
Contraindications and safety
While the Apidra Solostar Ready Pen is a reliable diabetes management tool, it is essential to be aware of its contraindications and safety considerations. Some contraindications include:
- Hypersensitivity to insulin glulisine or any components of the formulation
- Patients experiencing hypoglycemia
- Severe kidney or liver impairment, which can affect insulin metabolism
- Uncontrolled diabetes during periods of significant physical activity
Users should consult healthcare professionals before starting treatment to ensure it aligns with their overall health plans. Proper storage of the pen, maintaining temperature requirements, and disposing of used pens appropriately are vital in ensuring insulin effectiveness and safety. Regular blood glucose monitoring is crucial in managing diabetes and preventing complications from both high and low glucose levels. By adhering to these guidelines and consulting healthcare providers as needed, athletes and active individuals can safely integrate Apidra into their regimen, ensuring optimum health and performance.
| Active substance | Insulin Glulisine |
|---|---|
| Water Retention | Can cause modest water retention |
| Hepatotoxicity | No hepatotoxic effects known |
| Lab Test | Blood insulin levels, C-peptide test |
| Also known as | Exogenous insulin |
| Blood pressure | Can indirectly affect blood pressure by altering blood glucose levels |
| Trade name | Humulin, Novolin, Lantus, among others |
| Storage conditions | Must be kept refrigerated (2-8 degrees Celsius), avoid freezing |
| Chemical name | Insulin |
| Formula | C257H383N65O77S6 (for human insulin) |
| Substance class | Hormone, peptide |
| Main action | Lowers blood glucose levels |
| Half-life | Varies by type (Rapid-acting: 2-4 hours, Short-acting: 3-6 hours, Intermediate-acting: 12-18 hours, Long-acting: 20-24 hours) |
| Dosage (medical) | Depends on the patient's insulin sensitivity, carbohydrate intake, and blood glucose level, typically ranges from 0.5 to 1 unit/kg per day |
| Dosage (sports) | Not recommended for non-medical use |
| Effects | Decreases blood glucose, increases cellular glucose uptake, promotes glycogen synthesis |
| Side effects | Hypoglycemia, weight gain, insulin resistance, allergic reactions |
| Use in sports | Misused for anabolic purposes |
| Manufacturer | Sanofi |
| Packing | 1 pack (5 pens x 3ml (100 iu/ml)) |
| 5 |
|
0 |
| 4 |
|
0 |
| 3 |
|
0 |
| 2 |
|
0 |
| 1 |
|
0 |





Reviews
There are no reviews yet.